- 专利标题： ANTI-SLC1A4 MONOCLONAL ANTIBODIES AND USES THEREOF
-
申请号： EP22306787.7申请日： 2022-12-05
-
公开(公告)号： EP4382120A1公开(公告)日： 2024-06-12
- 发明人: LINARES, Laetitia , BOUILLIN, Alix , GAYTE, Laurie , CHENTOUF, Myriam , RISCAL, Romain , CARRERE, Sébastien , NEIVEYANS, Madeline
- 申请人： Institut Regional du Cancer de Montpellier , INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) , UNIVERSITE DE MONTPELLIER
- 申请人地址： FR 34090 Montpellier 208, rue des Apothicaires
- 专利权人： Institut Regional du Cancer de Montpellier,INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE),UNIVERSITE DE MONTPELLIER
- 当前专利权人： Institut Regional du Cancer de Montpellier,INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE),UNIVERSITE DE MONTPELLIER
- 当前专利权人地址： FR 34090 Montpellier 208, rue des Apothicaires
- 代理机构： Cabinet Nony
- 主分类号： A61K39/00
- IPC分类号： A61K39/00 ; C07K16/28 ; A61P35/04
摘要：
The present disclosure relates to monoclonal antibodies directed against the external loop of SLC1A4, which monoclonal antibodies are preferably human monoclonal antibodies.
The present disclosure also relates to the therapeutic use of the said monoclonal antibodies, especially for treating serine-dependent cancers, particular SLC1A4-expressing cancers. It also relates to the in vitro and the in vivo use of the anti-SLC1A4 monoclonal antibodies disclosed therein for diagnosis purpose.
The present disclosure also relates to the therapeutic use of the said monoclonal antibodies, especially for treating serine-dependent cancers, particular SLC1A4-expressing cancers. It also relates to the in vitro and the in vivo use of the anti-SLC1A4 monoclonal antibodies disclosed therein for diagnosis purpose.
信息查询
